Posted on 12 月 17, 202012/17/20
Achieve Price and Access Launch Excellence in a Disrupted World
Posted on 12 月 4, 202012/4/20
A New Pharmaceutical Strategy for Europe
Posted on 11 月 24, 202011/24/20
How Artificial Intelligence Is Transforming Pharma
Posted on 10 月 29, 202010/29/20
The U.S. Pharma Market Outlook: Path to Recovery and the New Normal
Posted on 9 月 14, 20209/14/20
At the COVID-19 Finish Line, How Do We Price The Winning Vaccine?
Posted on 8 月 10, 20208/10/20
How Pharma Can Meet Commercialization and Marketing Challenges During COVID-19
Posted on 7 月 7, 20207/7/20
Leading and Decision-Making in Uncertain Times
Posted on 7 月 2, 20207/2/20
ICER’s Alternative Pricing Models: New Threats to Biopharmaceutical’s Profitability and Innovation
Posted on 6 月 28, 20206/28/20
COVID-19’s Impact on Brand Access
Posted on 6 月 15, 20206/15/20